Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study

NCT03744741 is registered in ClinicalTrials.gov with Inflammatix as lead sponsor.

NCT NCT03744741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03744741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study
Lead sponsor
Inflammatix
Phase
Observational
Overall status
Completed
Start date
July 23, 2018
Completion date
January 20, 2020
Enrollment
585 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

intraabdominal infections, respiratory tract infections, sepsis, skin and soft tissue infections, urinary tract infections